Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 6
2005 14
2006 16
2007 13
2008 10
2009 6
2010 3
2011 1
2012 1
2013 1
2015 3
2016 2
2017 1
2018 2
2019 2
2020 2
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Early recurrence risk: aromatase inhibitors versus tamoxifen.
Bria E, Carlini P, Cuppone F, Vaccaro V, Milella M, Cognetti F. Bria E, et al. Among authors: carlini p. Expert Rev Anticancer Ther. 2010 Aug;10(8):1239-53. doi: 10.1586/era.10.54. Expert Rev Anticancer Ther. 2010. PMID: 20735310 Review.
Self-monitoring versus standard monitoring of oral anticoagulation.
Ferretti G, Giannarelli D, Carlini P, Felici A, Ciccarese M, Mandalà M, Cognetti F. Ferretti G, et al. Among authors: carlini p. Thromb Res. 2007;119(3):389-90. doi: 10.1016/j.thromres.2006.08.007. Epub 2006 Oct 4. Thromb Res. 2007. PMID: 17023029 Review. No abstract available.
Feasibility of cabazitaxel in octogenarian prostate cancer patients.
Tralongo P, Bordonaro S, Di Lorenzo G, De Giorgi U, Borsellino N, Facchini G, Rossetti S, Fornarini G, Longo V, Tralongo AC, Caspani F, Spada M, Calvani N, Carlini P. Tralongo P, et al. Among authors: carlini p. Curr Urol. 2023 Sep;17(3):153-158. doi: 10.1097/CU9.0000000000000081. Epub 2022 Aug 2. Curr Urol. 2023. PMID: 37448615 Free PMC article.
Exemestane or tamoxifen?
Ferretti G, Felici A, Carlini P, Cognetti F. Ferretti G, et al. Among authors: carlini p. Lancet. 2007 May 12;369(9573):1599; author reply 1600-1. doi: 10.1016/S0140-6736(07)60739-9. Lancet. 2007. PMID: 17499594 No abstract available.
Docetaxel in advanced gastric cancer--review of the main clinical trials.
Di Cosimo S, Ferretti G, Fazio N, Silvestris N, Carlini P, Alimonti A, Gelibter A, Felici A, Papaldo P, Cognetti F. Di Cosimo S, et al. Among authors: carlini p. Acta Oncol. 2003;42(7):693-700. doi: 10.1080/02841860310011014. Acta Oncol. 2003. PMID: 14690154 Review.
Aromatase inhibitors in post-menopausal metastatic breast carcinoma.
Carlini P, Bria E, Giannarelli D, Felici A, Papaldo P, Fabi A, Ruggeri EM, Milella M, Nuzzo C, Cecere FL, Gelibter A, Pino MS, Nisticò C, Cuppone F, Metro G, Terzoli E, Cognetti F, Ferretti G. Carlini P, et al. Expert Opin Investig Drugs. 2007 Jul;16(7):1023-36. doi: 10.1517/13543784.16.7.1023. Expert Opin Investig Drugs. 2007. PMID: 17594187 Review.
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model.
Strigari L, Pinnarò P, Carlini P, Torino F, Strolin S, Minosse S, Sanguineti G, Benassi M. Strigari L, et al. Among authors: carlini p. Crit Rev Oncol Hematol. 2016 Jun;102:101-10. doi: 10.1016/j.critrevonc.2016.04.004. Epub 2016 Apr 22. Crit Rev Oncol Hematol. 2016. PMID: 27157527 Review.
Targeting targeted agents: open issues for clinical trial design.
Bria E, Di Maio M, Carlini P, Cuppone F, Giannarelli D, Cognetti F, Milella M. Bria E, et al. Among authors: carlini p. J Exp Clin Cancer Res. 2009 May 22;28(1):66. doi: 10.1186/1756-9966-28-66. J Exp Clin Cancer Res. 2009. PMID: 19463172 Free PMC article. Review.
81 results